SCHEMBL18273201

SCHEMBL18273201

c1ccc(-c2ccc3c(c2)c2cc(-c4nc(-c5cccc6c5oc5ccccc56)c5oc6ccccc6c5n4)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.39
ALOX5 P09917 2/20 0.38
MAPT P10636 9/20 0.37
ALDH1A1 P00352 7/20 0.37
KDM4E B2RXH2 3/20 0.37
POLB P06746 3/20 0.37
HPGD P15428 2/20 0.37
LMNA P02545 5/20 0.37
HSD17B10 Q99714 3/20 0.37
MAPK1 P28482 2/20 0.37
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
NPSR1 Q6W5P4 3/20 0.36
KMT2A Q03164 5/20 0.36
MEN1 O00255 4/20 0.36
USP2 O75604 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18273197 0.95 ALOX5 (0.38) TSHRALOX5MAPTALDH1A1KDM4E
SCHEMBL20030042 0.93 ALDH1A1 (0.38) TSHRALOX5MAPTALDH1A1KDM4E
SCHEMBL18273178 0.91 TSHR (0.42) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL18273173 0.91 TSHR (0.42) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL18273203 0.91 ALOX5 (0.35) TSHRALOX5MAPTALDH1A1KDM4E
SCHEMBL20030248 0.90 PIM1 (0.38) TSHRALOX5MAPTALDH1A1KDM4E
SCHEMBL18273425 0.90 ALOX5 (0.36) TSHRALOX5MAPTALDH1A1KDM4E
SCHEMBL19537736 0.90 PIM1 (0.40) TSHRALOX5MAPTALDH1A1KDM4E
SCHEMBL16905791 0.89 TSHR (0.41) TSHRMAPTALDH1A1KDM4EPOLB
SCHEMBL16905866 0.89 TSHR (0.41) TSHRMAPTALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 TSHR 4456/4885ALOX5 1855/4885MAPT 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.